Skip To Main Content
Morgan Craig on Muck Rack

Morgan Craig

Toronto
As seen in: Wiley Online Library, PLOS, Frontiers, MDPI, Cell Reports Physical Science
growing my brows in. senior #pr manager

Get in touch with Morgan

Contact Morgan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Viral evolution during primary infection in immunocompromised hosts

|
By Morgan Craig, Département de Mathématiques
| PLOS
Loading metrics Open Access Peer-reviewed Research Article Citation: Craig M, Deng X, McLeod DV (2026) Viral evolution during primary infection in immunocompromised hosts. PLoS Comput Biol 22(2): e1013967. https://doi.org/10.1371/journal.pcbi.1013967 Editor: Philipp Martin Altrock, University Hospital Schleswig-Holstein - Campus Kiel: Universitatsklinikum Schleswig-Holstein, GERMANY Received: September 4, 2025; Accepted: February 2, 2026; Published: February 25, 2026 Copyright: © 2026 Craig et al.
Open in Who Shared Issue with article?

Virtual Clinical Trial Reveals Significant Clinical Potential of Targeting Tumor‐Associated Macrophages and Microglia to Treat Glioblastoma

|
By Blanche Mongeon, Morgan Craig
| Wiley Online Library Verified
CCL2 Chemokine (C-C motif) ligand 2 CD47 Cluster of differentiation 47 CSF Cerebrospinal fluid CSF1R Colony-stimulating factor-1 receptor ICI Immune checkpoint inhibitor IL-10 Interleukin-10 mAB Monoclonal antibody SI Supporting Information SOC Standard-of-care TAM Tumor-associated macrophages and microglia TCGA The Cancer Genome Atlas TGF-β Transforming growth factor beta TLR Toll-like receptors TME Tumor microenvironment TMZ Temozolomide VCT Virtual clinical trial What is the current...
Open in Who Shared Issue with article?

Tumor-mediated immunosuppression and cytokine spreading affects the relation between EMT and PD-L1 status

|
By Heiko Enderling, Morgan Craig, Marta Canel
| Frontiers
Carlijn M. Lems Gerhard A. Burger Joost B. Beltman* Division of Drug Discovery and Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, Netherlands Epithelial-mesenchymal transition (EMT) and immune resistance mediated by Programmed Death-Ligand 1 (PD-L1) upregulation are established drivers of tumor progression.
Open in Who Shared Issue with article?
See all 5 articles